Getting your Trinity Audio player ready...
|
A US team has effectively and efficiently used CRISPR/Cas9 to edit rhesus monkey embryos, in a proof of concept study
While human embryos have already undergone experimental editing in China, the US is yet to follow suit. Now, a research team has tested the editing system CRISPR-Cas9 on rhesus monkey embryos to test whether primate models could be used as improved human models for the development of new therapies such as gene or cell based therapeutics.“Using nonhuman primate embryos is important because the closer we can approximate the human condition in the animal model, the better the chances of developing successful treatments as well as limiting risks that may be encountered in clinical trials. If scientists want to test drugs for dementia, Alzheimer’s or autism, ideal models would react similarly to humans in regards to the reduction of symptoms, outbreak of side effects, such as enduring the same lesions as humans do, or exhibiting similar behavioral characteristics”
“Extreme amounts of care go into maintaining the well-being of the monkeys. They follow strict protocols to ensure this is a priority. So being able to conduct the science here at Michigan State while partnering with the center is the best combination of science and animal welfare”
Read more at MedicalXpressCopyright © Gowing Life Limited, 2025 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.